Analysts expect Biogen Inc. to report revenue of 2.72 B for Q4 26, against a range of 2.50 B to 2.94 B. The most recent reported quarter, Q3 26, came in at 2.80 B, a 11.4% beat against the 2.51 B consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.45 B | 2.43 B | 2.65 B | 2.53 B | 2.28 B | 2.48 B | 2.74 B | 2.80 B | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 2.45 B | 2.55 B | 2.31 B | 2.59 B | 2.17 B | 2.52 B | 2.78 B | 2.71 B | 2.94 B | 2.74 B | 3.09 B | 2.65 B | 2.84 B | 2.78 B | 3.04 B | 3.24 B | |||||||||
| Low Estimate | 2.19 B | 2.21 B | 2.16 B | 2.30 B | 1.93 B | 2.33 B | 2.35 B | 2.32 B | 2.50 B | 2.35 B | 2.58 B | 2.43 B | 2.53 B | 2.39 B | 2.84 B | 2.86 B | |||||||||
| Consensus Estimate | 2.32 B | 2.38 B | 2.23 B | 2.45 B | 2.05 B | 2.42 B | 2.57 B | 2.51 B | 2.72 B | 2.54 B | 2.83 B | 2.54 B | 2.69 B | 2.58 B | 2.94 B | 3.05 B |
Analysts expect Biogen Inc. to report earnings per share of 2.90 for Q4 26, against a range of 2.74 to 3.06. The most recent reported quarter, Q3 26, came in at 2.62, a 35.1% beat against the 1.94 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 3.44 | 3.02 | 5.47 | 4.81 | 1.99 | 3.57 | 3.60 | 2.62 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 3.34 | 3.33 | 4.31 | 4.33 | 1.63 | 3.30 | 3.34 | 2.03 | 3.06 | 3.62 | 4.74 | 4.54 | 3.30 | 4.47 | 5.62 | 5.46 | |||||||||
| Low Estimate | 3.12 | 2.87 | 4.03 | 3.63 | 1.45 | 3.06 | 2.86 | 1.85 | 2.74 | 3.30 | 4.16 | 4.06 | 2.86 | 3.93 | 5.20 | 4.60 | |||||||||
| Consensus Estimate | 3.23 | 3.10 | 4.17 | 3.98 | 1.54 | 3.18 | 3.10 | 1.94 | 2.90 | 3.46 | 4.45 | 4.30 | 3.08 | 4.20 | 5.41 | 5.03 |
Pull Wall Street consensus for Biogen Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BIIB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BIIB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BIIB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();